Gujarat Alkalies & Chemicals Ltd: Valuation Shifts Signal Price Attractiveness Challenges

Valuation Metrics Reflect Elevated Price Levels

The latest data reveals Gujarat Alkalies trading at a P/E ratio of 74.6, a steep increase that places it in the ‘very expensive’ valuation bracket. This is a marked change from its previous ‘risky’ valuation status, indicating that the market is pricing in substantial growth expectations or premium quality relative to earnings. However, this elevated P/E is considerably higher than many of its commodity chemical peers, such as Himadri Speciality Chemical at 49.8 and Navin Fluorine International at 57.7.

In contrast, the company’s price-to-book value (P/BV) stands at 0.95, which is below the typical threshold of 1.0, suggesting that the stock is trading close to its book value. This juxtaposition of a very high P/E with a sub-1 P/BV ratio is unusual and may reflect market scepticism about the company’s asset utilisation or profitability metrics.

Enterprise Value Multiples and Profitability Concerns

Examining enterprise value (EV) multiples, Gujarat Alkalies shows an EV to EBITDA ratio of 10.46, which is moderate compared to peers like Acutaas Chemicals at 48.8 and Himadri Speciality Chemical at 39.5. This suggests that while the stock is expensive on earnings multiples, its valuation relative to cash flow is more reasonable. However, the EV to EBIT ratio is extremely elevated at 56.45, signalling that operating profits are currently weak or negative.

Indeed, the company’s latest return on capital employed (ROCE) and return on equity (ROE) are negative at -0.17% and -0.05% respectively, highlighting ongoing profitability challenges. These negative returns raise questions about the sustainability of the current valuation premium and whether the market is overly optimistic about future turnaround prospects.

Stock Performance Outpaces Broader Market

Despite valuation concerns, Gujarat Alkalies has delivered impressive stock returns relative to the Sensex. Year-to-date, the stock has gained 33.5%, while the Sensex has declined by 10.75%. Over the past month, the stock rose 7.3% compared to a 1.2% fall in the benchmark. Even on a one-week basis, the stock surged 14.7% while the Sensex dropped 2.7%. This strong relative performance has contributed to the re-rating of the stock’s valuation multiples.

Longer-term returns are more mixed, with the stock delivering 12.3% over one year versus a -7.5% Sensex return, but lagging the Sensex over three years (1.6% vs 14.6%) and closely tracking over five and ten years. This suggests that recent momentum has been a key driver of the valuation shift rather than sustained fundamental improvement.

Comparative Valuation Within Commodity Chemicals Sector

When benchmarked against its commodity chemicals peers, Gujarat Alkalies stands out for its high P/E and relatively low EV to EBITDA multiples. For instance, Deepak Nitrite, classified as ‘expensive’, trades at a P/E of 40.2 and EV to EBITDA of 24.2, both significantly lower than Gujarat Alkalies. Similarly, Atul and Aarti Industries, rated as ‘fairly’ valued, have P/E ratios of 27.8 and 42.0 respectively, with EV to EBITDA multiples below 20.

The PEG ratio of Gujarat Alkalies is 0.25, which is low and typically indicates undervaluation relative to growth. However, given the negative profitability metrics, this low PEG may be misleading or reflective of market expectations for a sharp earnings turnaround. Peers such as Himadri Speciality Chemical and Navin Fluorine have PEG ratios of 1.83 and 0.46 respectively, suggesting more tempered growth assumptions.

Market Capitalisation and Trading Range

Gujarat Alkalies is classified as a small-cap stock, with a current price of ₹673.55, up 4.6% on the day from a previous close of ₹643.90. The stock has traded between ₹668.50 and ₹708.25 today, remaining below its 52-week high of ₹815 but well above the 52-week low of ₹410. This price action reflects strong investor interest despite valuation concerns.

Investment Grade and Mojo Score Update

The company’s Mojo Score has improved to 62.0, resulting in an upgrade from a ‘Sell’ to a ‘Hold’ rating as of 13 July 2026. This upgrade reflects a more balanced view of the stock’s prospects, acknowledging recent price appreciation and potential for recovery, while cautioning on stretched valuation and weak profitability.

Investor Takeaway: Balancing Growth Expectations and Valuation Risks

Investors considering Gujarat Alkalies must weigh the stock’s strong recent performance and market optimism against its elevated valuation multiples and negative returns on capital. The very high P/E ratio suggests that the market is pricing in a significant earnings turnaround or growth acceleration, which has yet to materialise in the company’s financials.

Comparisons with peers indicate that Gujarat Alkalies is trading at a premium that may be difficult to justify without a clear improvement in profitability metrics. The low PEG ratio could be attractive if the company delivers on growth, but the negative ROCE and ROE highlight ongoing operational challenges.

Given these factors, the current ‘Hold’ rating appears appropriate, signalling that investors should monitor upcoming earnings reports and operational developments closely before committing additional capital.

Conclusion: Valuation Premium Demands Caution

Gujarat Alkalies & Chemicals Ltd’s recent valuation shift to a ‘very expensive’ category underscores the importance of cautious analysis. While the stock’s price appreciation and relative outperformance against the Sensex are encouraging, the stretched P/E and negative profitability metrics temper enthusiasm.

Investors should remain vigilant for signs of operational improvement and earnings growth to justify the premium valuation. Until then, a ‘Hold’ stance is prudent, balancing the potential for upside with the risks inherent in the current price levels.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →